Learn About Vitiligo Treatment Options and Care

Understanding Vitiligo: What Happens to Your Skin

Vitiligo is a skin condition where patches of skin lose their color. This happens because the cells that make pigment, called melanocytes, stop working or die. The result is white or very light patches that can appear anywhere on the body. About 1 to 2 percent of people worldwide have vitiligo, making it more common than many realize.

The patches can be small or large, and they often start on the hands, feet, face, or lips. Some people develop just a few patches, while others see vitiligo spread across much of their body. The condition is not contagious and does not cause physical pain, but it can affect how people feel about their appearance.

Vitiligo happens when the body's immune system attacks the melanocytes. Scientists are still learning why this occurs, but genetics play a role—if family members have vitiligo, your risk increases. Other factors may include stress, skin injury, or exposure to certain chemicals. Some people notice their vitiligo started after a sunburn or emotional stress.

The condition progresses differently for each person. Some people's vitiligo spreads quickly over months, while others see slow changes over years. A few people experience no new patches after the initial appearance. There is no way to predict how vitiligo will progress in any individual.

Practical Takeaway: Understanding that vitiligo involves loss of skin pigment due to immune system changes helps you have realistic conversations with doctors and explore treatment options that may slow progression or restore color.

Topical Treatments: Creams and Ointments for Skin Patches

Topical treatments are medicines applied directly to the skin. They are often the first treatment doctors recommend, especially for vitiligo on the face, neck, and areas that are easier to reach. These treatments work by reducing inflammation and helping the body restore pigment to affected areas.

Corticosteroid creams are the most common topical treatment. These reduce inflammation and may help repigmentation begin. Potency levels vary—some corticosteroids are mild, while others are very strong. The strength your doctor recommends depends on where the vitiligo is located and how severe it is. For example, facial skin needs gentler medications than skin on the arms or legs.

Calcineurin inhibitors are another topical option. These include medicines like tacrolimus and pimecrolimus. Unlike corticosteroids, they do not thin the skin, making them useful for sensitive areas like the face. These work by calming the immune response in affected skin.

Vitamin D derivatives, such as calcipotriene, are sometimes used alone or combined with other topical treatments. Research shows they may help with repigmentation when used over several months. Results are often modest but can contribute to overall improvement.

Topical treatments require patience and consistency. It typically takes 3 to 6 months to see results, and some people see better results than others. Application instructions matter—using too little reduces effectiveness, while using more than prescribed does not improve results faster. Many people use topical treatments long-term to maintain any color restoration they achieve.

Practical Takeaway: Topical treatments work best for patches on accessible areas and require consistent application over months; asking your doctor about the strength appropriate for your skin location and expected timeline helps set realistic expectations.

Light-Based Therapies: UVB and Excimer Laser Treatments

Light-based therapies use ultraviolet (UV) light to stimulate the skin's pigment-producing cells and calm the immune response. These treatments have shown strong results for vitiligo, particularly for widespread patches or areas that are difficult to treat with creams alone.

Narrowband UVB (NB-UVB) therapy is the most studied light-based treatment for vitiligo. During treatment, you stand in a light box or sit under a light panel two to three times per week for short periods, typically 30 seconds to a few minutes. The light exposes affected areas to specific wavelengths of UV radiation. Over time—usually 6 months to over a year—many people see significant repigmentation. Studies show that about 45 to 60 percent of people treated with NB-UVB see at least 75 percent repigmentation on the body, though results on the face are often better than on hands and feet.

Excimer laser is a more targeted light therapy that uses a different wavelength. Instead of treating your whole body, the laser beam focuses on specific patches. This allows higher doses of light directly on problem areas and is useful when vitiligo is limited to certain body parts. Treatment typically occurs once or twice weekly. Some dermatologists combine excimer laser with topical treatments for better results.

Photochemotherapy, also called PUVA therapy, involves taking a light-sensitizing medication by mouth or applying it to the skin, then exposing the skin to UVA light. This approach is less common now because NB-UVB tends to work better with fewer side effects, but it remains an option some patients explore.

Light therapies do carry risks. UV exposure increases skin cancer risk slightly over many years, though the risk from medical light therapy is much lower than from sun exposure. You must wear protective eyewear during treatment, and dermatologists monitor your skin regularly. Light therapy also does not work for everyone—some people see excellent results while others see little change.

Practical Takeaway: Light-based therapies require a long-term commitment of multiple visits per week but show good success rates for many people; discussing whether your vitiligo pattern makes you a good candidate helps determine if this approach is worth trying.

Systemic Treatments: Oral Medications and Newer Options

Systemic treatments work throughout your whole body by mouth or injection rather than on specific skin patches. These are often considered when vitiligo is widespread, rapidly spreading, or not responding to topical and light treatments.

Oral corticosteroids can slow the progression of vitiligo, especially when the condition is actively spreading. Low doses taken for several months may prevent new patches from forming. However, long-term use of oral corticosteroids comes with side effects like weight gain, weakened bones, and increased infection risk, so doctors use this approach cautiously and typically only for limited periods.

JAK inhibitors represent a newer category of systemic treatment. These medications target specific immune system pathways involved in vitiligo. Ruxolitinib (Opzelura) is a JAK inhibitor approved by the FDA specifically for vitiligo as a topical cream, but oral JAK inhibitors are also being studied for vitiligo and show promise in clinical trials. This class of medication works differently from older treatments by targeting the root immune cause rather than just reducing inflammation. Early results are encouraging, with some patients experiencing substantial repigmentation.

Antioxidant supplements like vitamin E, vitamin C, and alpha-lipoic acid may help by reducing oxidative stress, which some researchers believe plays a role in vitiligo. While these are available over-the-counter, evidence for their effectiveness is modest. Some people use them alongside medical treatments, though you should discuss any supplements with your doctor.

Immunosuppressive drugs like azathioprine or mycophenolate are occasionally used for severe, rapidly progressing vitiligo. These reduce overall immune system activity but carry significant side effects and require careful monitoring by specialists.

Practical Takeaway: Systemic treatments address vitiligo throughout the body and may be needed for widespread disease, but they require more monitoring and have more potential side effects than topical treatments; discussing the trade-offs between benefit and risk with your dermatologist is essential.

Surgical and Cosmetic Options for Skin Restoration

When medical treatments do not achieve satisfactory results, surgical options may help restore skin appearance. These procedures are typically considered after medical treatments have been tried for at least several months, since some skin naturally repigments over time with treatment.

Skin grafting transfers pigmented skin from one body part to depigmented patches. In autologous skin grafting, the surgeon removes a small area of your normal-colored skin and places it over the vitiligo patch. The transplanted skin brings melanocytes that may spread into surrounding depigmented skin. This works best for stable vitiligo that is not rapidly spreading. Success rates